Search Results - "BALLESTER, Oscar"

Analysis of trunk impact conditions in motorcycle road accidents based on epidemiological, accidentological data and multibody simulations by Cherta Ballester, Oscar, Llari, Maxime, Afquir, Sanae, Martin, Jean-Louis, Bourdet, Nicolas, Honoré, Valentin, Masson, Catherine, Arnoux, Pierre-Jean

“…•A representative analysis of PTW crash configurations based on clinical data.•Definition of human body impact conditions using multibody simulations.•The most…”
Get full text

An evaluation methodology for motorcyclists' wearable airbag protectors based on finite element simulations by Cherta Ballester, Oscar, Llari, Maxime, Honoré, Valentin, Masson, Catherine, Arnoux, Pierre-Jean

“…A method to evaluate the effectiveness of wearable airbag protectors for motorcyclists is proposed in this work. The mitigation of thoracic injury severity in…”
Get full text

RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials by Witte, Theodore R, Salazar, Alexander J, Ballester, Oscar F, Hardman, W Elaine

“…Results from increasing numbers of in vitro and in vivo studies have demonstrated that omega 3 fatty acids incorporated in cell culture media or in the diet of…”
Get full text

Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids by Fahrmann, Johannes F., Ballester, Oscar F., Ballester, Gabriela, Witte, Theodore R., Salazar, Alexander J., Kordusky, Benjamin, Cowen, Kelsey G., Ion, Gabriela, Primerano, Donald A., Boskovic, Goran, Denvir, James, Hardman, W. Elaine

“…Targeting the nuclear factor kappa B (NFκB) pathway is proposed as therapy for chronic lymphocytic leukemia (CLL). We hypothesized that an omega-3 fatty acids…”
Get full text

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial by STEWART, A. Keith, VESCIO, Robert, STIFF, Pat, MEHARCHARD, Jacinta, SCHLOSSMAN, Robert, BROWN, Randy, TULLY, Heather, BENYUNES, Mark, JACOBS, Cindy, BERENSON, Ronald, WHITE, Michael, DIPERSIO, John, SCHILLER, Gary, ANDERSON, Kenneth C, BERENSON, James, BALLESTER, Oscar, NOGA, Stephen, RUGO, Hope, FREYTES, Cesar, STADTMAUER, Edward, TARANTOLO, Stefano, SAHEBI, Firoozeh

“…Although high-dose chemotherapy supported by autologous peripheral-blood progenitor-cell (PBPC) transplantation improves response rates and survival for…”
Get full text

Traffic collisions and micromobility: A comparison between personal mobility devices and bicycles based on police reports by Guesneau, Marianne, Cherta-Ballester, Oscar, Agier, Lydiane, Arnoux, Pierre-Jean, Wei, Wei, Vernet, Céline, Honoré, Valentin, Bailly, Nicolas

“…•Out of 20,420 collisions involving PMDs and bicycles from in a national police report database, 75% involved a car.•Side-on-head collision was the most common…”
Get full text

Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools by Tirona, Maria Tria, Sehgal, Rajesh, Ballester, Oscar

“…ABSTRACT Advances in breast cancer research have led to declining death rates from this disease because of early detection through mammographic screening and…”
Get full text

Cytogenetic Alterations in Multiple Myeloma: Prognostic Significance and the Choice of Frontline Therapy by Stella, Flavia, Pedrazzini, Estela, Agazzoni, Mara, Ballester, Oscar, Slavutsky, Irma

“…Multiple myeloma tumor cells demonstrate multiple and often complex genetic lesions as evaluated by standard cytogenetic/FISH studies. Over the past decade,…”
Get full text

Frontline Therapy for Multiple Myeloma: A Concise Review of the Evidence Based on Randomized Clinical Trials by Yaqub, Sobia, Ballester, Gabriela, Ballester, Oscar

“…The past decade has seen significant progress in the development of new and effective therapies for multiple myeloma. Stem cell transplantation and the…”
Get full text

The Emperor's New Clothes or the Current Practice of Clinical Trials for Multiple Myeloma in the USA by Ballester, Oscar

“…Phase III clinical trials help define standard therapies by comparing the outcomes of a new (experimental) treatment arm to the best established (control) arm…”
Get full text

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial by Richardson, Paul G, Legieć, Wojciech, Larocca, Alessandra, Reece, Donna, Špička, Ivan, Ganetsky, Alex, Popa McKiver, Mihaela, Lonial, Sagar, Dimopoulos, Meletios A, Bahlis, Nizar J, Beksaç, Meral, Petrucci, Maria T, Mateos, María-Victoria, Špička, Ivan, Kaufman, Jonathan L, Lonial, Sagar, Podhorecka, Monika, Besemer, Britta, De Fabritiis, Paolo, Emanuele, Angelucci, Bladé, Joan, Casado, Luis F, Panelli, Victoria, Benson, Don, Reeves, James, Lech-Marańda, Ewa, Acs, Peter, De Prijck, Bernard, Sebag, Michael, Modiano, Manuel, Wright, Matthew P, Vekemans, Marie-Christine, Gutiérrez, María AE, Driessen, Christoph, Behl, Rajesh, Moezi, Mehdi, Cortes, Hector V, Horvath, Noemi, D'Rozario, James M, Latimer, Maya, Mittelman, Moshe, Vacca, Angelo, Jędrzejczak, Wiesław W, Robak, Tadeusz, Ruiz, Marco, Alencar, Alvaro, Kasbari, Samer, Cohen, Gary, Jakubowiak, Andrzej, Rosenbaum, Cara, Delforge, Michel, Demuynck, Hilde, Schots, Rik, Blau, Igor W, Dürk, Heinz A, Munder, Markus, Scheid, Christof, Symeonidis, Argiris S, Illés, Árpád, Coyne, Mark, O'Gorman, Peter, Hayden, Patrick, Ben-Yehuda, Dina, Braester, Andrei, Lugassy, Gilles, Bosi, Alberto, Pezzatti, Sara, Pogliani, Enrico M, Goñi, María A, Carboneras, Ana V, Rubenstein, S. Eric, Khojasteh, Ali, Liman, Andrew, Stockerl-Goldstein, Keith, Strnad, Charles, Stuart, Robert, Jhangiani, Haresh, Filshie, Robin, Hertzberg, Mark S, Kotb, Rami, Mügge, Lars-Olof, Kyriakou, Despoina, Clotilde, Cangialosi, Musuraca, Gerardo, Vladareanu, Ana-Maria, Encinas, Cristina, Gayoso, Jorge, Pabst, Thomas, Rabin, Neil, Sahovic, Entezam, Khasawneh, Mohamad, Sehgal, Rajesh, Lunning, Matthew, Vose, Julie, Faber, Edward, MacFarlane, Donald, Hohl, Raymond, Mahmood, Tariq, Bhaskar, Birbal, Richard, Robert

“…Elotuzumab plus lenalidomide and dexamethasone has shown improved progression-free and overall survival versus lenalidomide and dexamethasone in patients with…”
Get full text

Does Upfront Therapy with Fludarabine Increase the Risk of Histological Transformation In Patients with Follicular Lymphoma? by Yaqub, Sobia, Gress, Todd W., Ballester, Oscar

“…Abstract 4885 Fludarabine has been reported to increase the incidence of relapse and histological transformation in chronic lymphocytic leukemia (Thornton PD,…”
Get full text

Prevention of Breast Cancer (Part II): Risk Reduction Strategies by Tirona, Maria Tria, Sehgal, Rajesh, Ballester, Oscar

“…ABSTRACT Until recently, the best protection against breast cancer mortality was early diagnosis through mammographic screening. However, the possibility that…”
Get full text

Abbreviated, Dose Dense Fludarabine and Rituximab for Elderly Patients with Indolent B Cell Malignancies by Ballester, Gabriela, Frazer, Lisa, Tirona, Maria, Ballester, Oscar F

“…Abstract 4796 Therapy for indolent B cell malignancies is primarily palliative. Therefore limiting toxicities by reducing drug exposure is desirable,…”
Get full text

Oral Supplementation with Omega3 Fatty Acids Inhibits NFkB Activation In Chronic Lymphocytic Leukemia (CLL) Cells by Ballester, Oscar F. F, Fahrmann, Johannes, Witte, Theodore, Ballester, Gabriela, Hardman, W. Elaine

“…Abstract 4607 Nuclear factor kappa B (NFkB) is a critical transcription factor involved in the growth and survival of CLL cells. NFkB is recognized as an…”
Get full text

Therapeutic Dilemma of Chemotherapy Dosing in Morbidly Obese Patient with AML: A Case Report and a Review of the Literature by Hussain, Sakeer, Glass, Jonathan, Ballester, Oscar

“…Obesity is a common and increasing problem affecting the developed world. There is no consensus on a standard approach to chemotherapy dosing has been adopted…”
Get full text

Therapy-Related Acute Lymphoblastic Leukemia (t-ALL) by Escobar, Carolina, McLarty, Jerry, Ballester, Oscar

“…Introduction: Myelodysplasia and Acute Myeloid Leukemia are recognized and well characterized complications of cancer therapy. Much less is known about t-ALL,…”
Get full text

Inhibition of nuclear factor kappa B activation in early stage chronic lymphocytic leukemia by omega 3 fatty acids by Fahrmann, Johannes Francois, Ballester, Oscar, Ballester, Gabriela, Witte, Theodore, Salazar, Alexander, Ion, Gabriela, Primerano, Donald, Boskovic, Goran, Denvir, James, Hardman, Elaine

“…Abstract only Targeting the NFκB pathway has been proposed for therapy of various malignancies including chronic lymphocytic leukemia (CLL). Omega 3 (n‐3)…”
Get full text

Hodgkin's Lymphoma in the Elderly Patient: Impact of Age and Co-Morbidities On Outcomes by Nakkar, Samer, Pacioles, Toni, Ballester, Gabriela, Tirona, Maria, Ballester, Oscar F

“…Abstract 4529 Age older than 45 years is a recognized independent prognostic factor for patients with Hodgkin's Lymphoma (HL), and it is part of the…”
Get full text

Effects of An Omega 3 Fatty Acid Supplement Consumption On Platelet Aggregation Tests in Patients Low Grade Lymphoproliferative Disorders by Ballester, Gabriela, Salazar, Alexander, Witte, Theodor, Hardman, Elaine, Griswold, Doreen, Ballester, Oscar F

“…Abstract 5076 Omega 3 fatty acids, when supplemented to cell culture or in the diet of tumor bearing animals, have been shown to sensitize mouse leukemias and…”
Get full text